Abstract
Integrated Safety From Phase 2 Studies of Monotherapy Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (MM): An Updated Analysis
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have